Anika Therapeutics, Inc. (NASDAQ:ANIK)

CAPS Rating: 5 out of 5

The Company develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.

Caps

How do you think ANIK will perform against the market?

Add Stock to CAPS Watchlist

All Players

252 Outperform
7 Underperform
 

All-Star Players

28 Outperform
2 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top ANIK Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

staylo2561 (< 20)
Submitted March 11, 2014

The new approved drug is based on HRA, and is a one injection shot to the knee for osteoarthritis. I have taken HRA for years....It is a miracle drug.

tunstavurn (< 20)
Submitted March 02, 2011

Pending lawsuit with genzyme.declining marginsIncreased competition

ANIK VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about ANIK.

Recs

0
Member Avatar wstanislaw (29.07) Submitted: 7/7/2015 6:15:01 PM : Outperform Start Price: $32.57 ANIK Score: -22.84

Great financials, zero debt, under valued based on growth history and potential. High demand got content arthritis treatment and a growing market if baby boomers will expand that demand. More potential in European and global markets, and existing foreign subsidiaries.

Recs

0
Member Avatar healthcarevalue (91.39) Submitted: 3/31/2015 6:43:30 PM : Outperform Start Price: $41.18 ANIK Score: -45.91

ANIK - Anika Therapeutics Inc. - negligible to zero debt/equity ratio. Return on Invested Capital (ROIC) = 24.43 TTM. Price/earnings ratio of 16.4 TTM is reasonable. Niche biotech healthcare industry company specializing in therapeutic products for tissue repair and multiple different treatments in increasing demand by baby boomers.

Recs

0
Member Avatar puneetkataria (< 20) Submitted: 3/1/2015 1:47:37 AM : Outperform Start Price: $39.96 ANIK Score: -40.50

Great fundamentals and a huge market for the products.

Leaderboard

Find the members with the highest scoring picks in ANIK.

Score Leader

zebradave

zebradave (66.91) Score: +1,020.27

God be with you.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
mechming < 20 12/7/2010 Outperform 5Y $5.53 +545.75% +120.86% +424.89 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. acts20 50.59 9/30/2011 Outperform NS $5.41 +560.07% +137.82% +422.25 2 Comments
siri22 < 20 9/1/2011 Outperform NS $6.00 +495.17% +123.84% +371.33 1 Comment
danculbertson 62.09 8/10/2010 Outperform 5Y $5.90 +505.25% +144.34% +360.92 0 Comment
vin100r < 20 8/12/2011 Outperform 3W $6.05 +490.25% +131.19% +359.06 0 Comment
germantownrockvi < 20 12/14/2010 Outperform 5Y $6.20 +475.97% +119.42% +356.54 0 Comment
cerroalegre 39.60 12/15/2010 Outperform 5Y $6.34 +463.25% +119.97% +343.28 0 Comment
mechincl < 20 10/25/2010 Outperform 5Y $6.33 +464.14% +129.75% +334.38 0 Comment
gsabc 81.27 6/25/2010 Outperform 5Y $6.16 +479.71% +154.07% +325.64 1 Comment
5starman < 20 6/1/2011 Outperform 5Y $7.09 +403.67% +105.09% +298.58 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.23 10/28/2016 Outperform 3W $43.00 -16.95% +28.79% -45.74 0 Comment
TrackWayneRogers 58.63 11/29/2013 Outperform 3M $34.35 +3.96% +51.23% -47.27 0 Comment
tracksummerstree 91.99 9/19/2011 Outperform NS $5.72 +524.30% +129.81% +394.49 0 Comment
TrackNCPI < 20 11/7/2007 Outperform NS $14.86 -74.29% -47.61% -26.68 12/1/2008 @ $3.82 0 Comment

Advertisement